Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by-nc (c) Darbà, Josep et al., 2016
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/107753

A budget impact analysis of Spiromax compared with Turbuhaler for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

To assess the economic impact of the introduction of DuoResp(®) Spiromax(®) by focusing on a potential improvement in the inhalation technique to strengthen medication adherence for the treatment of moderate to severe asthmatics in Spain and five Spanish regions including Andalusia, Catalonia, Galicia, Madrid, and Valencia. ...

Citació

Citació

DARBÀ, Josep, RAMÍREZ, Gabriela, GARCÍA-RIVERO, Juan l., MAYORALAS, Sagrario, PASCUAL, José francisco, ROGER, Albert, VARGAS, Diego, BIJEDIC, Adi. A budget impact analysis of Spiromax compared with Turbuhaler for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions. _Clinicoeconomics and Outcomes Research_. 2016. Vol. 8, núm. 435-444. [consulta: 20 de gener de 2026]. ISSN: 1178-6981. [Disponible a: https://hdl.handle.net/2445/107753]

Exportar metadades

JSON - METS

Compartir registre